Related references
Note: Only part of the references are listed.Alternatively spliced androgen receptor variants
Scott M. Dehm et al.
ENDOCRINE-RELATED CANCER (2011)
Characterising the castration-resistant prostate cancer population: a systematic review
M. Kirby et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
Inhibition of Glycogen Synthase Kinase-3β Counteracts Ligand-Independent Activity of the Androgen Receptor in Castration Resistant Prostate Cancer
Stefanie V. Schuetz et al.
PLOS ONE (2011)
JS-K; a nitric oxide-releasing prodrug, modulates β-catenin/TCF signaling in leukemic Jurkat cells: Evidence of an S-nitrosylated mechanism
Niharika Nath et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
JS-K has potent anti-angiogenic activity in vitro and inhibits tumour angiogenesis in a multiple myeloma model in vivo
Tanyel Kiziltepe et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
Nitric Oxide Inhibits the Proliferation and Invasion of Pancreatic Cancer Cells through Degradation of Insulin Receptor Substrate-1 Protein
Hiroki Sugita et al.
MOLECULAR CANCER RESEARCH (2010)
Nitric Oxide-Releasing Silica Nanoparticle Inhibition of Ovarian Cancer Cell Growth
Ellen V. Stevens et al.
MOLECULAR PHARMACEUTICS (2010)
Limitations of MTT and MTS-Based Assays for Measurement of Antiproliferative Activity of Green Tea Polyphenols
Piwen Wang et al.
PLOS ONE (2010)
Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
Philip A. Watson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Nitro-aspirin inhibits MCF-7 breast cancer cell growth: Effects on COX-2 expression and Wnt/β-catenin/TCF-4 signaling
Niharika Nath et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Recent Advances on the Roles of NO in Cancer and Chronic Inflammatory Disorders
Jagat R. Kanwar et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Biochemical and cellular toxicology of peroxynitrite: implications in cell death and autoimmune phenomenon
Rizwan Ahmad et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2009)
Phase II Study of Nitric Oxide Donor for Men With Increasing Prostate-specific Antigen Level After Surgery or Radiotherapy for Prostate Cancer
D. Robert Siemens et al.
UROLOGY (2009)
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
Scott M. Dehm et al.
CANCER RESEARCH (2008)
Crosstalk between the Androgen Receptor and beta-Catenin in Castrate-Resistant Prostate Cancer
Gang Wang et al.
CANCER RESEARCH (2008)
Inhibition of glycogen synthase kinase-3 in androgen-responsive prostate cancer cell lines:: Are GSK inhibitors therapeutically useful?
Ludwig Rinnab et al.
NEOPLASIA (2008)
Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence
Stephen J. Libertini et al.
CANCER RESEARCH (2007)
JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cells
Tanyel Kiziltepe et al.
BLOOD (2007)
Nuclear localization and DNA binding of ecdysone receptor and ultraspiracle
M. V. Cronauer et al.
ARCHIVES OF INSECT BIOCHEMISTRY AND PHYSIOLOGY (2007)
Nitric oxide-mediated inhibition of androgen receptor activity:: possible implications for prostate cancer progression
M. V. Cronauer et al.
ONCOGENE (2007)
Nitric oxide-induced down-regulation of β-catenin in colon cancer cells by a proteasome-independent specific pathway
Laurent Prevotat et al.
GASTROENTEROLOGY (2006)
Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells
X. Yang et al.
ONCOGENE (2006)
Rapid nitric oxide-mediated S-nitrosylation of estrogen receptor:: Regulation of estrogen-dependent gene transcription
HJ Garbán et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Photosensitive precursors to nitric oxide
CM Pavlos et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2005)
Nitrosulindac (NCX 1102): A new nitric oxide-donating non-steroidal anti-inflammatory drug (NO-NSAID), inhibits proliferation and induces apoptosis in human prostatic epithelial cell lines
S Huguenin et al.
PROSTATE (2004)
Nitric oxide donating nonsteroidal anti-inflammatory drugs induce apoptosis in human prostate cancer cell systems and human prostatic stroma via caspase-3
JS Royle et al.
JOURNAL OF UROLOGY (2004)
EosFP, a fluorescent marker protein with UV-inducible green-to-red fluorescence conversion
J Wiedenmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Constitutive activation of the androgen receptor by a point mutation in the hinge region: A new mechanism for androgen-independent growth in prostate cancer
J Ceraline et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Rapid spectrophotometric method for serum glutathione S-transferases activity
M Habdous et al.
CLINICA CHIMICA ACTA (2002)
The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cells
MW Chen et al.
ONCOGENE (2002)
Nitric-oxide releasing molecules: A new class of drugs with several major indications
JL Burgaud et al.
CURRENT PHARMACEUTICAL DESIGN (2002)
Share Paper
